Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma.

Hayley M ReynoldsBimal K ParameswaranMary E FinneganDiana RoettgerEddie LauTomas KronMark ShawSarat ChanderShankar Siva

Published in: PloS one (2018)

DWI and DCE MRI parameters show potential as early response biomarkers after SABR for primary RCC. Further prospective validation using larger patient cohorts is warranted.

Keyphrases

contrast enhanced
diffusion weighted
renal cell carcinoma
magnetic resonance imaging
diffusion weighted imaging
magnetic resonance
computed tomography
high resolution
early stage
case report
locally advanced
small cell lung cancer
radiation induced
risk assessment
climate change
mass spectrometry
brain metastases